NASDAQ: TRDA - Entrada Therapeutics, Inc.

Rentabilidade por seis meses: +44.28%
Setor: Healthcare

Cronograma de promoção Entrada Therapeutics, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs.

Mais detalhes
The company's lead therapeutic candidates, which include ENTR-601-44 and ENTR-601-45, which are in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1; ENTR-501, an intracellular thymidine phosphorylase enzyme replacement therapy, which is in preclinical trail for the treatment of mitochondrial neurogastrointestinal encephalomyopathy; and ENTR-701, which is in preclinical trail for the treatment of myotonic dystrophy type 1. Entrada Therapeutics, Inc. has a strategic collaboration and license agreement with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize ENTR-701. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

Цена ао 13.76
EBITDA -0.0117
Число акций ао 0.03305 млрд
P/BV 1.79
EV/EBITDA 1.44
ISIN US29384C1080
Сайт https://www.entradatx.com
Выручка 0.0253
P/S 18.67
Валюта usd
IPO date 2021-10-29
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Alteração de preço por dia: 0% (17.53)
Alteração de preço por semana: +8.41% (16.17)
Alteração de preço por mês: +16.87% (15)
Alteração de preço em 3 meses: +3.85% (16.88)
Mudança de preço em seis meses: +44.28% (12.15)
Mudança de preço por ano: +15.71% (15.15)
Mudança de preço desde o início do ano: +5.16% (16.67)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 4.28 4
P/BV 2.28 6
P/E 0 0
EV/EBITDA -1720.37 0
Total: 5

Eficiência

Nome Significado Nota
ROA, % -1.42 0
ROE, % -2.76 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -212.55 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 410.74 10
Rentabilidade Ebitda, % -97.26 0
Rentabilidade EPS, % -43.91 0
Total: 3.2
Mais detalhes

Instituições Volume Compartilhar, %
Baker Brothers Advisors, LLC 4865819 14.48
Mpm Asset Management, LLC 4425784 13.17
5AM Venture Management, LLC 4408379 13.12
Price (T.Rowe) Associates Inc 3009673 8.96
Blackrock Inc. 1502537 4.47
Redmile Group, LLC 1283735 3.82
Vanguard Group Inc 1065166 3.17
Wellington Management Group, LLP 1047780 3.12
StepStone Group LP 761277 2.27
Tcg Crossover Management, Llc 584955 1.74

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Avantis U.S Small Cap Equity ETF 0.04469 27.774101036841 1.68271
Avantis Responsible U.S. Equity ETF 0.00307 26.778312788906 1.45257
Avantis U.S. Equity ETF 0.00145 32.224830464267 1.59151
Avantis U.S. Small Cap Value ETF 0.00122 29.302558956347 2.3212
Dimensional U.S. Core Equity 2 ETF 0.00003 30.755198832543 1.47098
Dimensional U.S. Targeted Value ETF 0.00098 26.007247921552 1.93487
Dimensional US Core Equity Market ETF 0.00096 30.983243755928 1.40618
Dimensional US Small Cap Value ETF 0.00252 25.854782942758 1.97866
Dimensional U.S. Equity ETF 0.00027 31.530984204131 1.3557
WisdomTree U.S. SmallCap Fund 0.07886 31.540809405381 1.80258
First Trust Dow Jones Select MicroCap Index Fund 0.52221 26.184578018465 1.56612
Fidelity MSCI Health Care Index ETF 0.00401 13.390080209527 1.46057
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05026 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.00207 5.9237999659878 1.47892
iShares Neuroscience and Healthcare ETF 0.59012 19.720292847757 0.03
iShares Micro-Cap ETF 0.09211 36.318555985322 1.54048
iShares Russell 3000 ETF 0.00074 32.57283798366 1.43482
Nuveen ESG Small-Cap ETF 0.02399 29.971671388102 1.41019
Schwab U.S. Small-Cap ETF 0.00715 34.281650071124 1.51433
Schwab U.S. Broad Market ETF 0.00046 32.5 1.43354
ProShares UltraPro Russell2000 0.00784 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 ETF 0.02 35.648084105685 1.48801



Supervisor Cargo Pagamento Ano de nascimento
Mr. Dipal Doshi CEO & Director 968.21k 1976 (48 anos)
Mr. Nathan J. Dowden President & COO 694.3k 1971 (53 ano)
Dr. Natarajan Sethuraman Ph.D. Chief Scientific Officer 694.3k 1962 (62 ano)
Mr. Kory James Wentworth CPA CFO & Treasurer N/A 1979 (45 anos)
Dr. Jared Cohen J.D., Ph.D. General Counsel N/A
Ms. Kerry Robert M.S. Senior Vice President of People N/A
Ms. Karla MacDonald Chief Corporate Affairs Officer N/A
Mr. Kevin Healy Ph.D. Senior Vice President of Regulatory Affairs N/A

Endereço: United States, Boston. MA, 6 Tide Street - abrir no Google Maps, abrir mapas Yandex
Site: https://www.entradatx.com